Alzheimer’s breakthrough: Scientists restore two hours of sleep without clearing brain plaques
Researchers have restored two hours of nightly sleep in Alzheimer's models by targeting microglia rather than amyloid plaques.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
Scientists have achieved a breakthrough in treating sleep loss associated with Alzheimer's disease. The research indicates that two hours of sleep were restored without the need to clear brain plaques.
Coverage from Medical Xpress, ScienceDaily, and Tech Times emphasizes that brain immune cells—specifically microglia—are the true cause of sleep loss, rather than amyloid plaques. UKNow further identifies the researchers involved as being based in the UK.
Future focus will likely center on the role of microglia in Alzheimer's disease as an alternative target for treating sleep disturbances.
Synthesized by Archynetys from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 1h ago.
Quick answers
How much sleep was restored in this study?
Researchers restored two hours of nightly sleep.
What was identified as the cause of sleep loss in Alzheimer's?
According to Medical Daily and Tech Times, brain immune cells known as microglia are the cause, not amyloid plaques.
Did the breakthrough involve clearing brain plaques?
No, the sleep restoration occurred without clearing brain plaques.
Coverage (5)
- Two hours of sleep restored: Researchers make Alzheimer's breakthrough Medical Xpress · 1d ago
- Alzheimer’s Sleep Loss Traced to Microglia, Not Plaques: Two Hours Nightly Restored Tech Times · 1d ago
- Brain Immune Cells, Not Amyloid Plaques, Are the True Cause of Sleep Loss in Alzheimer's Disease, New Study Finds Medical Daily · 1d ago
- Two hours of sleep restored: UK researchers make Alzheimer’s breakthrough UKNow · 1d ago
- Alzheimer’s breakthrough: Scientists restore two hours of sleep without clearing brain plaques ScienceDaily · 1d ago
Topics
Related trends
Scientists discover a protein that protects the brain from Alzheimer’s damage
Scientists have identified the SORLA protein as a potential defense mechanism against Alzheimer's damage and toxic tau tangles.
Alzheimer's: Real-world study confirms Leqembi therapy benefits
FDA approval of an at-home subcutaneous starter dose for Leqembi coincides with a real-world study confirming the therapy's benefits.
Rare Autopsy Finds Alzheimer's Drugs Only Work in Some Parts of The Brain
New clinicopathologic research indicates that Alzheimer's drugs targeting amyloid plaques exhibit varying efficacy across different regions of the brain.
Alzheimer's blood test may predict who's likely to develop symptoms in 5 to 10 years
A new blood test may predict Alzheimer's risk up to a decade before symptoms appear.
Study shows a blood test can help identify healthy people at high risk for Alzheimer's disease
A new blood test may predict Alzheimer's disease risk in healthy individuals years before symptoms appear.
All eyes on data on Biogen’s tau therapy
Biogen's experimental anti-tau therapy, diranersen, shows promise in slowing cognitive decline for early Alzheimer's patients.